For information about the application process, fee , accommodation and programme, please send your questions to enquiry@siog.org.

Why attend

In a rapidly aging world where cancer rates are rising especially among the older population, innovation driven by research based on evidence and centered on the patient is more crucial than ever. Individuals aged 70 and above are particularly affected and account for the largest proportion of cancer-related deaths globally. Despite this, the care they receive falls short when compared to other age groups. The misconception that older adults have a lower treatment tolerance contributes to this, leading to under-representation in trial registration. There is a strong emphasis from regulatory bodies on the need to include patients aged 75 and above. Yet, very often, at the time of registration of new drugs, fewer older cancer patients are enrolled — resulting in a skewed output of tolerance in the ‘non-fit’ older population.

This cutting-edge programme on Study Design equips you with essential attributes in designing clinical studies centered on the unrepresented older adult population. If you want to prepare yourself for the burgeoning medical landscape of Geriatric Oncology and broaden your arsenal of study design tools in GO—be it clinical trial design, observational studies, or cohort studies – the SIOG Research Masterclass is where you need to be.

Who Should Attend

This three-day course is designed for early-career clinical investigators, researchers, healthcare professionals, and industry experts, including:

Medical Oncologists, Surgeons, Hematologists, Epidemiologists, Advanced Practice Nurses (APN), Oncology Nurses, Allied Health Professionals (such as Occupational Therapists and Physiologists), Psychologists, Pharmacists, Industry Professionals, and Clinical PhD candidates.

Objective

The SIOG Masterclass offers world-class training to clinical investigators with the aim of addressing hidden inclusion criteria that inevitably exclude older cancer patients in randomised control studies/ trials. The course will help participants develop concepts on GO study designs that is ready for submission at their institutions.

Benefits

  • A 3 day-course formatted to offer an exceptional educational experience
  • Exclusive guidance by an international faculty in geriatric oncology
  • Unique opportunity to build your network in geriatric oncology research
  • Access to SIOG Membership and its related benefits

Scientific Committee

Prof. Dr. Florence Canouï-Poitrine (FR)
Prof. Dr. Florence Canouï-Poitrine (FR)National Convenor & Committee Member
Dr. Loïc Mourey (FR)
Dr. Loïc Mourey (FR)National Convenor & Committee Member
Dr. Capucine Baldini (FR)
Dr. Capucine Baldini (FR)Course Director
Prof. Dr. Etienne Brain (FR)
Prof. Dr. Etienne Brain (FR)Committee Member
Prof. Dr. Martine Extermann (US)
Prof. Dr. Martine Extermann (US)Committee Member
Dr. Marcus Vetter (CH)
Dr. Marcus Vetter (CH)Committee Member
Dr. Vérène Dougoud (CH)
Dr. Vérène Dougoud (CH)Committee Member

Supported by:

DETAILS

Start: March 19, 2025

End: March 21, 2025

Venues: Paris, France

  • Day 1 & Day 2: Gustave Roussy
    • 114 Rue Edouard Vaillant, 94800 Villejuif, France
  • Day 3: Unicancer
    • Okabé, 67 Av. de Fontainebleau, 94270 Le Kremlin-Bicêtre, France
Days before Event
0
0
0
0
Days
0
0
Hrs
0
0
Min
0
0
Sec